Insomnia treating drug

Abstract

The invention provides a medicament for treating insomnia with natural plant extract as the medicinal active composition, wherein the medicament is an oral preparation of purple stem feverwort extract and pharmaceutically acceptable medicinal auxiliary materials. The extract can be water extract, alcohol extract, ether extract, and chloroform extract.

Description

technical field [0001] The invention relates to a medicine for treating insomnia, which uses natural plant extracts as medicinal active ingredients. technical background [0002] Neurasthenia is a common and frequently-occurring disease in neuropsychiatry. According to statistics, its incidence rate accounts for more than 10% of the normal population in developing countries and 20% in developed countries. Because of its stubbornness and intractability, it is called "undead cancer". Insomnia is one of the main symptoms of neurasthenia. According to incomplete statistics, 20%-30% of people in my country suffer from sleep disorders to varying degrees. Sleep disorders lead to damage to multiple systems of the human body, and are complicated by hypertension, arrhythmia, cerebrovascular disease, diabetes and kidney disease. Most of the clinically used treatments for insomnia are diazepam, such as alprazolam, triazolam, clonazepam, diazepam, and midazolam. The effective rate of...

AI Technical Summary

Problems solved by technology

However, the data show that after the continuous drug withdrawal of diazepam, some patients have withdrawal symptoms; alprazolam combined with digoxin appears poisoning, induces manic episodes, and induces hypoorgasm; according to some studies, pregnancy Fetal malformations caused by taking diazepam include cleft palate, cleft lip, or inguinal hernia, etc.